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ABSTRACT
Background: Unhealthy behaviors, such as
energy-dense food choices and a sedentary life-
style, both of which are established risk factors
for diabetes, are common and increasing among
Nepalese adults. Previous studies have reported
a wide variation in the prevalence of prediabetes
and diabetes in Nepal, and thus a more reliable
pooled estimate is needed. Furthermore, Nepal
underwent federalization in 2015, and the pro-
vince-specific prevalence, which is necessary for
the de novo provincial government to formu-
late local health policies, is lacking. This study
aims to provide a comprehensive summary of
the current literature on various aspects of dia-
betes in Nepal, i.e., the prevalence of predia-
betes and diabetes as well as of the awareness,
treatment, and control of diabetes in Nepal.
Methods: This review was conducted according
to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guide-
lines. We searched three electronic databases—
PubMed, Scopus, and Web of Science—using a
comprehensive search strategy to identify eli-
gible studies published up to April 2, 2020. Data
on prevalence estimates of prediabetes and
diabetes were extracted and pooled in a meta-
analysis using a random effect model. Subgroup
analyses and meta-regression were conducted to
assess heterogeneity across the studies. The
quality of included studies was assessed using
the New Castle-Ottawa scale.
Results: We included 14 eligible studies that
comprised a total of 44,129 participants and
3517 diabetes cases. Half of the included studies
had good quality. Overall, the prevalence of
prediabetes and diabetes was 9.2% (95% CI
6.6–12.6%) and 8.5% (95% CI 6.9–10.4%),
respectively. Among the participants with dia-
betes, only 52.7% (95% CI 41.7–63.4%) were
aware of their diabetes status, and 45.3% (95%
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CI 31.6–59.8%) were taking antidiabetic medi-
cations. Nearly one-third of those under
antidiabetic treatment (36.7%; 95% CI
21.3–53.3%) had their blood glucose under
control. The prevalence of prediabetes and dia-
betes gradually increased with increasing age
and was more prevalent among males and
urban residents. There was a wide variation in
diabetes prevalence across the provinces in
Nepal, the lowest 2% in Province 6 to the
highest 10% in Province 3 and Province 4.
Conclusions: The prevalence of prediabetes and
diabetes was high in Nepal, while its awareness,
treatment, and control were low. Our findings
call for urgent nationwide public health action
in Nepal.
Keywords: Diabetes; Meta-analysis; Nepal;
Prevalence; Systematic review
Key Summary Points
Very little is known about the burden of
diabetes and prediabetes, treatment and
control across provinces of Nepal.
Current evidence, using systematic review
and meta analyses of 14 studies
comprising 44,129 participants and 3517
diabetes cases, suggests prediabetes
prevalence of 9.2% and diabetes
prevalence of 8.5%.
Only a half of patients with diabetes were
aware of their diabetic status, and even
fewer were taking antidiabetic
medication. Only a third of those under
therapy had their blood glucose under
control.
This study further suggests that prevalence
of prediabetes and diabetes increased with
age and was most prevalent among males
and urban residents. Prevalence of
diabetes was fivefold higher in Province 3
and Province 4 compared to Province 6.
BACKGROUND
The burden of diabetes has posed insurmount-
able challenges in both low- and high-income
countries [1]. In 2019, an estimated 463 million
adults worldwide, aged 20–79 years, lived with
diabetes, and the number is predicted to
increase to 700 million by 2045 [2]. Moreover,
nearly half of diabetes cases remain undiag-
nosed, leading to various complications such as
neuropathy, nephropathy, retinopathy, cardio-
vascular disease, and stroke [3, 4]. Nearly 21%
and 13% of the deaths from ischemic heart
disease and stroke, respectively, were attributed
to high blood glucose levels [5, 6]. Although
two-thirds of people with diabetes are believed
to reside in low- and middle-income countries
(LMICs), the actual estimates of diabetes burden
and deaths are still unknown because of limited
data from LMICs [2].
South Asia, the most populous region in the
world, is home to nearly two-thirds of all global
diabetes cases. One-fifth of all adults in South
Asia have diabetes, and the number has nearly
doubled between 1990 and 2016 in countries
like India [7, 8]. Diabetes literature in South Asia
is predominantly from India, and little is known
about the overall burden of diabetes in Nepal, a
South Asian country between India and China,
which has recently witnessed an epidemiologic
transition and subsequent growing epidemic of
chronic conditions [9]. In 2017, nearly 10,145
deaths were attributed to diabetes, which was
also ranked as the 11th most common cause of
disability-adjusted life years (DALYs) in Nepal
(1226 DALYs per 10,000 population) [10]. Ear-
lier studies from Nepal have reported a wide
variation in diabetes prevalence, ranging from
0.8 to 19%. Thus, a more reliable pooled esti-
mate is needed. A previous systematic review
based on ten studies published between 2000
and 2014 reported a prediabetes and diabetes
prevalence of 10.3% (95% CI 6.1–14.4%) and
8.4% (95% CI 6.2–10.5%), respectively [11].
Given that most of the included studies in the
previous meta-analysis [11] had a small sample
size and were limited by geography and that
recently nationwide estimates have been
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published [12, 13], an update to the previous
meta-analysis is deemed important.
Early detection and proper management of
diabetes can delay disease progression, includ-
ing a significant reduction in the risk of dia-
betes-related complications [14]. It is
noteworthy that in low-income settings like
Nepal, individuals present themselves to a
health provider only when symptoms are obvi-
ous; consequently, the actual burden of disease
is highly underreported. Therefore, focusing
only on prevalent diabetes may undermine the
true burden and mislead preventive strategies.
Hence, stakeholders should be cognizant of
other aspects of diabetes, such as the hidden
burden of prediabetes, as well as the awareness,
treatment, and control of diabetes among the
general population. Currently, our knowledge
of the prevalence of prediabetes, as well as on
the awareness, treatment, and control of dia-
betes, mostly come from small-sized studies
limited to small geographies [15]. We have the
opportunity to provide more reliable estimates
by pooling the previous studies.
Moreover, and most importantly, Nepal
underwent federalization in 2015 with signifi-
cant restructuring of the nation’s administrative
units and handed the administrative authority
to the local provincial governments. However,
so far, province-specific estimates in the context
of Nepal’s new federal set up are lacking, which
may hinder devising an appropriate strategy for
curbing the diabetes epidemic in Nepal, specif-
ically at the administrative or provincial level.
Hence, with an overarching aim of providing
a comprehensive summary of the current liter-
ature on various aspects of diabetes in Nepal,
this study, using a meta-analytical approach,
will estimate the (1) pooled prevalence of pre-
diabetes and diabetes nationwide, (2) pooled
prevalence of prediabetes and diabetes by pro-
vinces, and (3) prevalence of awareness, treat-
ment, and control of diabetes in Nepal.
METHODS
Data Sources and Search Strategy
This review was conducted in accordance with
the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines
[16]. Two authors (NS and SRM) searched three
databases—PubMed, Scopus, and Web of Sci-
ence—using a comprehensive search strategy to
identify eligible studies published in the English
language up to April 2, 2020. Search terms used
were ‘‘diabetes,’’ ‘‘prevalence,’’ ‘‘blood glucose,’’
‘‘glucose intolerance,’’ and ‘‘Nepal.’’ Secondary
searches that included screening the references
of the included studies and the previous sys-
tematic review [11] resulted in the identification
of an additional five eligible studies for full-text
screening (Fig. 1). Study selection and eligibility
criteria, data extraction and quality assessment,
and data synthesis and analysis are described in
detail in supplementary methods. This article is
based on previously conducted studies and does
not contain any studies with human partici-
pants or animals performed by any of the
authors.
RESULTS
Literature Search, Characteristics
and Quality of Included Studies
The search strategy identified 662 citations. An
additional five studies were identified from
secondary searches. A total of 351 non-dupli-
cate studies were retrieved and were assessed for
the title and abstract screening (Fig. 1). Exclu-
sion of irrelevant and non-original studies
resulted in 19 studies for full-text screening.
Five studies were excluded for the following
reasons: self-reported diabetes and no data on
diabetes prevalence by age groups. Finally, 14
studies [12, 15, 17–28] were included in this
systematic review and meta-analysis.
The characteristics of the included studies
are provided in Table 1. Briefly, the 14 studies
together had a total of 44,129 participants and
3517 diabetes cases. We included only
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participants aged C 20 years old in the analysis.
Similarly, prediabetes prevalence was reported
in only ten studies with 22,658 participants and
3401 prediabetes cases. Except for one study
[23], all included studies provided prevalence
estimates for diabetes by gender, whereas four
included studies [12, 17, 21, 26] provided simi-
lar estimates by urban/rural residence. Most of
the included studies reported data from Pro-
vince 1, Province 3, and Province 4. Only two
nationwide studies reported data for all seven
provinces of Nepal [12, 17].
Diabetes was defined in the included studies
as previous physician-diagnosed diabetes, and/
or taking antidiabetic medications, and/or a
fasting blood glucose (FBG) of C 126 mg/dl
(7.0 mmol/l) or a 2-h oral glucose tolerance test
(OGTT) blood glucose level of C 200 mg/dl
(11.1 mmol/l). Seven studies reported using FBG
for diabetes diagnosis [15, 17, 19, 21, 24, 26, 27],
five studies reported using both FBG and OGTT
[12, 18, 20, 25, 28], one used FBG/urine [23],
and one used the OGTT method [22]. These
criteria for defining diabetes came from the
World Health Organization (1985 and 1999)
[29, 30] and the 1997 criteria from the American
Diabetes Association (ADA) or its updates
[31, 32]. Prediabetes was defined in the included
studies as FBG level between 100 (5.6 mmol/l)
and 125 mg/dL (\7 mmol/l) or a 2-h OGTT
blood glucose level between 140 (7.8 mmol/l)
and 199 mg/dl (11 mmol/l).
The definition of diabetes awareness, treat-
ment, and control was consistent between the
included studies. Participants were considered
to be aware of their diabetes status if a physician
had previously told them that they had dia-
betes. Treatment of diabetes was defined as the
current use of antidiabetic prescriptions. Con-
trol of diabetes was defined as a fasting blood
Fig. 1 PRISMA flow diagram for study selection for the systematic review and meta-analysis
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glucose level\126 mg/dl among those under
antidiabetic medication.
According to the New Castle-Ottawa scale,
only half of the included studies were scored as
good or very good quality (score 9–10) (Sup-
plementary Table 1). Specifically, six studies
scored lower in the selection bias domain
[18, 20, 22, 24, 26, 27], and nine studies scored
lower in the comparability bias domain
[18–24, 26, 27] (Supplementary Table 1).
Prevalence of Prediabetes and Diabetes
The pooled prevalence of prediabetes and dia-
betes was found to be 9.2% (95% CI 6.6–12.6%)
and 8.5% (95% CI 6.9–10.4%), respectively
(Figs. 2, 3). However, there was substantial
heterogeneity (I2 = 97%) across the studies
(Figs. 2, 3). The symmetrical funnel plot, as well
as the non-significant Egger test, suggested no
publication bias (p value 0.629) (Supplementary
Fig. 1).
In the subgroup analysis by age, sex, and
urban/rural residence, the prevalence of both
prediabetes and diabetes gradually increased
with increasing age (Supplementary Figs. 2 and
3) and was more prevalent among males and
urban residents (Supplementary data). The high
heterogeneity in the prevalence of prediabetes
and diabetes, noted in the main analysis,
existed even in the subgroup analysis by age
(Supplementary Figs. 2 and 3) and gender
(Supplementary data). Variation in the burden
of prediabetes and diabetes was seen across
provinces; prediabetes was most prevalent in
Province 7 (19.0%; 95% CI 16.0–21.0%),
whereas diabetes was more prevalent in Pro-
vince 3 (10.0%; 95% CI 5.0–14.0%) and Pro-
vince 4 (10.0%; 95% CI 6.0–14%) (Fig. 4 and
Supplementary data).
In the meta-regression, the regression coef-
ficient for the survey year, for both prediabetes
and diabetes, was positive, but the finding was
statistically non-significant (p = 0.067; Supple-
mentary Figs. 4 and 5).
Awareness, Treatment, and Control
of Diabetes
Among the participants with diabetes, around
half of the participants were aware of their
diabetes status (52.7%; 95% CI 41.7–63.4%).
Less than half of the participants were taking
antidiabetic medicines (45.3%; 95% CI
31.6–59.8%). Among those under antidiabetic
medication, only around one third had their
blood glucose controlled (36.7%; 95% CI
21.3–53.3%) (Supplementary Fig. 6).
Fig. 2 Pooled prevalence of prediabetes among Nepalese adults (C 20 years)
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DISCUSSION
This study comprehensively appraised the
prevalence of prediabetes and diabetes among
Nepalese adults. The pooled prevalence from
the meta-analysis showed a high prevalence of
prediabetes (9.2%) and diabetes (8.5%) but low
awareness (52.7%) and treatment (45.3%)
among diabetes patients and low diabetes con-
trol (36.7%) among those under antidiabetic
treatment.
Our estimated prevalence for prediabetes was
lower than in some of the previous studies from
Nepal [12, 15, 21, 27] but comparable to others
[18, 19, 25, 26]. Similarly, our estimated preva-
lence for diabetes was higher than in the earlier
nationwide STEPS 2013 survey (3.6%) [17] but
comparable to a recent nationwide survey on
the prevalence of selected NCDs in Nepal (8.3%)
[12]. A rapid surge in diabetes prevalence in
recent years in Nepal is predicated based on the
local social and cultural factors such as
increasing urbanization and changes in food
and lifestyle-related behaviors [33]. Increasing
urbanization and urban-centric economic pros-
perity also incur rural to urban migration of
population with changes in lifestyles [30]. The
Fig. 3 Pooled prevalence of diabetes among Nepalese adults (C 20 years)
Fig. 4 Prevalence of prediabetes and diabetes disaggregated by Nepal’s provinces (C 20 years)
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rural population with high physical activities
and low-calorie diets who have migrated to
urban cities often change their diet to fast and
junk food high in refined carbohydrates, sugar,
and fats coupled with minimal physical activi-
ties [33]. In addition, the urban cities in Nepal
neither have exercise-friendly spaces nor are the
currently available spaces conducive to exercise
because of commercial encroachment, high air
pollution levels, and low awareness of benefits
of exercise [30]. Paradoxically, the improving
economy in Nepal seems to facilitate a more
sedentary lifestyle, with a high intake of food
(increase in affordability) with minimal energy
expenditure [33]. Our findings corroborate the
epidemiologic transition and increasing dia-
betes prevalence in the South Asian region [34]
Notably, cardio-metabolic and chronic dis-
eases risk factors are high among the Nepalese
population. The 2013 STEPS survey reported
that only 0.4% of the Nepali population was
completely free of the eight established risk
factors for non-communicable diseases [35]. In
another study, about 68% of the participants
had at least one cardiometabolic risk factor [36].
These facts imply that in the absence of effec-
tive intervention strategies against diabetes, its
burden may continue to rise among Nepalese.
In fact, our coefficient from the meta-regression
analysis suggested an increasing trend in dia-
betes prevalence from 1990 to 2017, although
the finding was statistically non-significant,
which could be due to a smaller number of
studies (n = 14).
The findings related to the high prevalence
of prediabetes and low prevalence of awareness,
treatment, and control were concerning and
may further explain the high burden of diabetes
noted in this study. The prediabetes population
is a crucial subgroup of interest because an
estimated 5–10% of the prediabetes population
progress into diabetes annually if no lifestyle
intervention is initiated [37]. More than half of
the participants with diabetes were unaware of
their conditions or lacked treatment, which
implies that they may not be benefiting from
screening services or receiving regular care and/
or may be unable to afford high treatment costs
associated with diabetes. Although similar
findings from Nepal are lacking, low awareness
has been reported in global settings [38–41].
Previously, low awareness, treatment, and con-
trol of hypertension have been documented in a
nationwide study among the Nepalese [42].
Given that timely diagnosis and prompt man-
agement of diabetes can prevent progression
into diabetes complications, policymakers and
stakeholders should be cognizant of such proxy
indicators to prevent future epidemics.
We found a wide variation in diabetes
prevalence across the provinces in Nepal, the
lowest 2% in Province 6 to the highest 10% in
Province 3 and Province 4. The province-wise
differences in diabetes prevalence may also
account for the high heterogeneity across the
studies in our meta-analysis because the inclu-
ded studies that we pooled in the meta-analysis
were conducted across different regions in
Nepal. Diabetes is an important tracer of
urbanization and is markedly shaped by envi-
ronmental, social, political, and commercial
determinants of health [30, 33, 43]. Province 3,
the most developed province in Nepal with a
human development index (HDI) of 0.560, had
a nearly fivefold higher prevalence of diabetes
compared to Province 6, the least developed
province in Nepal with an HDI of 0.486 [44].
Provinces with greater rates of urbanization
have also become a flashpoint for dietary tran-
sition with increased consumption of plant fat,
sugar, and animal products [45]. The province-
wise differences in diabetes burden may have
policy implications at the local level. In the
immediate term, provincial and municipal
governments should take the initiative to
increase awareness on lifestyle-related behav-
iors, including creating exercise-enabling envi-
ronments such as allocation of public spaces,
parks, and greeneries [30, 33]. Since the
provincial set-up of Nepal is a recent phe-
nomenon, information on health indicators at
the provincial level is currently unavailable.
Our study is the first of its kind to provide the
burden of diabetes at the provincial level. Given
that the provincial government is responsible
for local governance, it may find the results
helpful in understanding the local needs and
identifying inequalities so that areas for public
health actions can be prioritized.
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Individual characteristics such as increasing
age, male gender, and urban residence were
associated with increased prevalence of diabetes
in our study and are consistent with previous
studies from Nepal [11, 17, 46] and across the
globe [39, 40, 47, 48]. Urban areas saw a two-
fold higher prevalence than rural areas. The
urban-rural disparity in health outcomes is evi-
dent globally [49, 50] and also exists in Nepal
[35]. Specifically, a sedentary lifestyle and access
to high-calorie processed food and sugar-
sweetened beverages are high in urban areas of
Nepal, which increases the likelihood of dia-
betes among urban residents [35].
Limitations
This major limitation of this study is the high
heterogeneity between the reported diabetes
prevalence across the included studies. We
could not perform additional subgroup analysis
for the factors that may have contributed to
heterogeneity across the included studies, such
as the diagnostic method. We also could not
perform a sensitivity analysis by removing
studies that scored to be of poor quality or had a
high risk of bias. Only two nationwide studies
were available, and other included studies were
mostly from Province 1 and 3. Additionally,
there was a paucity of studies that reported on
awareness, treatment, and control of diabetes
from all over Nepal. Hence, it was not feasible to
generate province-wise data for awareness,
treatment, and control of diabetes. We did not
include studies published in local journals that
were not indexed in the selected databases and
studies published in a non-English language.
Nevertheless, we conducted comprehensive
searches of three different databases to ensure
that all relevant publications are included.
In line with the Sustainable Development
Goals, the Multi-Sectoral Action Plan for
Prevention and Control of NCDs by the gov-
ernment of Nepal aims to reduce NCDs,
including diabetes, by one quarter by 2025 [51].
With a high burden of diabetes on the one hand
and low awareness and treatment as well as
poor availability of services for its prevention
and management on the other [52], achieving
such a goal may be challenging. Understanding
the disease burden and identifying the high-risk
populations and existing inequalities can help
the provincial and federal government to pri-
oritize resources and develop targeted inter-
ventions to meet such goals.
CONCLUSIONS
The prevalence of prediabetes and diabetes is high
in Nepal, whereas its awareness, treatment, and
control are low. Inequalities in the prevalence
were seen at the provincial or the local govern-
ment level and by individual characteristics. Fur-
ther studies are needed to understand the
underlying geographic drivers of the growing
diabetes epidemic in Nepal. Given the scarcity of
prevalence estimates at the provincial level, fur-
ther studies in the provinces with limited data on
the prevalence of prediabetes and diabetes, as well
as nationwide studies with provincial-level infor-
mation on awareness, treatment, and control of
diabetes, are warranted. Our findings call for
urgent nationwide public health actions such as
screening people at risk of diabetes and preven-
tion measures of the disease. Particularly mass
screening aimed to identify the prediabetes cases
and increasing awareness on diabetes manage-
ment and lifestyle behaviors may be important.
The findings can also inform local stakeholders
and policymakers to prioritize areas for public
health action and/or develop targeted interven-
tions for the at-risk populations to curb the dia-
betes epidemic in Nepal.
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